Proximal Risk for Suicide in Adolescents

Last updated: May 1, 2024
Sponsor: Oregon Health and Science University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Suicide

Treatment

Analog Devices Inc.

Clinical Study ID

NCT06400810
STUDY00022262
  • Ages 13-17
  • All Genders

Study Summary

The central hypothesis is that biometric data can continuously monitor and allow for early identification/intervention of escalating suicidal symptoms. The rationale is that improved outpatient monitoring through wearable technology can create a more objective platform to provide the ability to identify a worsening condition and utilize patient-specific just-in-time therapeutics developed with mental health providers for suicidal adolescents.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • subjects aged 13-17 years
  • presenting to the ED or inpatient psychiatric unit with a chief complaint of acutesuicidality or attempt.

Exclusion

Exclusion Criteria:

  • acutely agitated patients per the treating physician
  • adolescents who are not medically cleared from a suicide attempt
  • no legally authorized representative available to provide consent
  • parental report of significant developmental delay or autism diagnosis
  • prisoners
  • non-English speaking.

Study Design

Total Participants: 144
Treatment Group(s): 1
Primary Treatment: Analog Devices Inc.
Phase:
Study Start date:
June 15, 2023
Estimated Completion Date:
July 01, 2026

Study Description

Suicide rates have exponentially increased, and it is now the 2nd leading cause of death in adolescence, accounting for over 1.2 million annual emergency department (ED) visits. After an ED visit or attempt, up to 20% of adolescents will have a second attempt within 12 months, and almost half will have a repeat ED visit. This proposal's overall objectives are to investigate physiologic parameters and biometric data from wearable technology that is temporally related to suicidal behavior and develop a personalized, predictive tool that can improve outpatient identification of adolescent patients with suicidality before a crisis develops requiring an ED visit. The central hypothesis is that biometric data can continuously monitor and allow for early identification/intervention of escalating suicidal symptoms. The rationale is that improved outpatient monitoring through wearable technology can create a more objective platform to provide the ability to identify a worsening condition and utilize patient-specific just-in-time therapeutics developed with mental health providers for suicidal adolescents. To attain the overall objectives, I will pursue the following specific aims: (i) To evaluate whether HRV, combined with patient-specific risk factors, can be used to detect dynamic changes in suicide severity among a prospective cohort of acutely suicidal adolescents, (ii) To utilize machine learning to determine whether there is a temporal relationship/signature in the raw PPG signal before or immediately after changes in suicide severity reporting combined with patient-specific risk factors to develop a prediction tool for suicidality risk. These aims will be accomplished in three years through a prospective observational study enrolling acutely suicidal adolescents in the ED and an inpatient psychiatric unit. Ultimately, such knowledge can offer unique opportunities for early detection, just-in-time interventions, and support over 1.2 million suicidal adolescents presenting to EDs nationally.

Connect with a study center

  • OHSU

    Portland, Oregon 97239
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.